Latest Postoperative nausea and vomiting Stories
CHARLESTON, S.C., April 16, 2013 /PRNewswire/ -- Charleston Laboratories, Inc, an emerging specialty pharmaceutical company focused on the research and development of novel pain products that prevent or significantly reduce nausea and vomiting related to opioid analgesics and other pain associated disease states, announced today the U.S. Food and Drug Administration has granted its request for a Pre-IND meeting to discuss the proposed Investigational New Drug, CL-H1T, as a novel...
NEWPORT, R.I., July 25, 2012 /PRNewswire/ -- Migraine can be a disabling neurological disorder, often aggravated by accompanying nausea. Stimulation of the acupoint PC6 Neiguan, an approach to controlling nausea adopted by traditional Chinese medicine, has never been documented by published clinical studies in medical literature for the control of migraine-related nausea, until now. Published in the May 2012 Neurological Sciences (journal of the Italian Neurological Society)(1),...
CAMBRIDGE, England, May 28, 2012 /PRNewswire/ -- Acacia Pharma announces positive results from its Phase II study of APD421, in the prevention of post-operative nausea & vomiting (PONV). The study showed that APD421 significantly reduced the incidence of nausea and vomiting compared to placebo in adult surgical patients at moderate-to-high risk of suffering PONV. Vomiting and especially nausea remain a major problem for patients after surgical operations, despite the...
WARREN, N.J., July 11, 2011 /PRNewswire/ -- MonoSol Rx, a specialty pharmaceutical company and the developers of the PharmFilm® technology platform, in collaboration with APR Applied Pharma Research s.a. of Switzerland ("APR"), announced today that its FDA-approved anti-emetic Zuplenz (Ondansetron) oral soluble film is available for licensing to new commercial partners. The Company made the strategic decision to reacquire the commercial rights to Zuplenz from Strativa Pharmaceuticals,...
Vomiting is unpleasant. Nearly 30% of all patients suffer from nausea and vomiting after surgery. The financial repercussions of this are longer patient stays in the recovery room, with increased need for personnel. Appropriate prophylaxis and treatment can prevent postoperative nausea and vomiting. In a systematic review of the literature, Dirk Rüsch and co-authors investigate how treatment recommendations for nausea after general anesthesia can be improved (Dtsch Arztebl Int 2010;...
WOODCLIFF LAKE, N.J., July 2 /PRNewswire/ -- Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication. The FDA approval was granted...
NEWPORT BEACH, Calif., Jan. 5 /PRNewswire/ -- January 4, 2010 marked the dismissal of Dr. Barry Friedberg from his voluntary association with the University of California, Irvine (UCI) Anesthesia Department. Barry Friedberg, M.D. Champion of Anesthesia Patient Safety Friedberg, a prominent, board certified anesthesiologist, offered to help with a long needed Level I study to validate the cost-effectiveness of his internationally recognized PK (propofolketamine) anesthesia. His recent...
ZURICH, Switzerland, March 20 /PRNewswire/ -- A new, innovative study shows that a single dose of palonosetron, the second generation 5-HT3 antagonist, plus dexamethasone not only prevents chemotherapy-induced nausea and vomiting (CINV), but also allows adequate caloric intake in oncology patients. Data presented today at the ESMO Symposium on Cancer and Nutrition in Zurich, Switzerland New data presented today at the ESMO (European Society of Medical Oncology) Symposium on Cancer...
PK anesthesia denied Level I validation for Postoperative Nausea and Vomiting (PONV) CORONA DEL MAR, Calif., March 11 /PRNewswire/ -- Pulse oximeters became available in 1983, making each patient's oxygen status known on a beat-by-beat basis. Not until 1990, did the American Society of Anesthesiologists (ASA) say that all patients should have this monitor. No articles on this critical safety subject appear in the ASA Newsletter on their web site between 1983 and 1990. Action: In 1983, Dr....
After a tonsillectomy, it seems patients are caught in a Catch-22. New research shows a commonly used steroid to reduce nausea and vomiting is associated with an increased risk of postoperative bleeding.About 186,000 tonsillectomies are performed each year in the United States, making the outpatient procedure one of the most frequently performed surgical procedures in children. Dexamethasone injected after the start of anesthesia can reduce the nausea and vomiting often experienced after...
